Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-3044-2020Class II

TDDA Drugs of Abuse Cup(AMT Item/ AMT Description): TDDA-6MBAU-CUP /"TDDA Drugs of Abuse Cup...

Ameditech, Inc. / initiated 2020-08-18 / Terminated / root cause: manufacturing process

Ameditech Inc began a recall of TDDA Drugs of Abuse Cup(AMT Item/ AMT Description): TDDA-6MBAU-CUP /"TDDA Drugs of Abuse Cup AMP300/BZO200/COC300/MET300/OPI300/ THC50 with Cr, Ni, pH, Bl... on . FDA classified it as Class II and gives the reason as "Various immunoassay enzymes failed product performance, thereby the products do not consistently detect all calibrator and secondary compounds at the levels stated in the labeling". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-3044-2020
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Ameditech, Inc.
Product
TDDA Drugs of Abuse Cup(AMT Item/ AMT Description): TDDA-6MBAU-CUP /"TDDA Drugs of Abuse Cup AMP300/BZO200/COC300/MET300/OPI300/ THC50 with Cr, Ni, pH, Bl, S.G."
Product code
DIO Enzyme Immunoassay, Cocaine And Cocaine Metabolites
Reason for recall
Various immunoassay enzymes failed product performance, thereby the products do not consistently detect all calibrator and secondary compounds at the levels stated in the labeling.
Root cause tag
manufacturing process
FDA root cause
Process control
Action
A Field Corrective Action Notice letter was sent to affected consignees. The Customer notifications commenced on 19-Aug-2020. The consignees are requested to return all non-expired product in their possession to the recalling firm. Method of Notification, 1st contact: Written field corrective action notification letters will be sent via certified mail with delivery tracking to each consignee along with a pre-paid return label to return any product remaining in stock. 2nd & 3rd contact: Telephone, follow up email, or written mail communication will be used as necessary.
Quantity in commerce
26,775 units
Distribution
US - Nationwide OUS - Australia, France, Germany, New Zealand, Singapore and Spain
Product codes and lots
ALL Lots Within Expiry

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-3044-2020
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-3029-2020Class IITerminatedVoluntary: Firm initiated
Z-3030-2020Class IITerminatedVoluntary: Firm initiated
Z-3031-2020Class IITerminatedVoluntary: Firm initiated
Z-3032-2020Class IITerminatedVoluntary: Firm initiated
Z-3033-2020Class IITerminatedVoluntary: Firm initiated
Z-3034-2020Class IITerminatedVoluntary: Firm initiated
Z-3035-2020Class IITerminatedVoluntary: Firm initiated
Z-3036-2020Class IITerminatedVoluntary: Firm initiated
Z-3037-2020Class IITerminatedVoluntary: Firm initiated
Z-3038-2020Class IITerminatedVoluntary: Firm initiated
Z-3039-2020Class IITerminatedVoluntary: Firm initiated
Z-3040-2020Class IITerminatedVoluntary: Firm initiated
Z-3041-2020Class IITerminatedVoluntary: Firm initiated
Z-3042-2020Class IITerminatedVoluntary: Firm initiated
Z-3043-2020Class IITerminatedVoluntary: Firm initiated
Z-3044-2020Class IITerminatedVoluntary: Firm initiated
Z-3045-2020Class IITerminatedVoluntary: Firm initiated
Z-3046-2020Class IITerminatedVoluntary: Firm initiated
Z-3047-2020Class IITerminatedVoluntary: Firm initiated
Z-3048-2020Class IITerminatedVoluntary: Firm initiated
Z-3049-2020Class IITerminatedVoluntary: Firm initiated
Z-3050-2020Class IITerminatedVoluntary: Firm initiated
Z-3051-2020Class IITerminatedVoluntary: Firm initiated